27.05.2020
- Gilead Sciences has tapped five generic drugmakers as partners to further expand supplies of remdesivir, its drug now being trialed in the US as a Covid-19 treatment. Non-exclusive...
31.03.2020
- Biopharmaceutical producer Gilead Sciences has surprised the market by asking the US Food and Drug Administration (FDA) to rescind the orphan drug status of its experimental...
04.03.2020
- Gilead Sciences has agreed to buy out immuno-oncology company Forty Seven for $4.9 billion. The deal, which has unanimous approval from both boards, is expected to close in the...
23.07.2019
- Galapagos and Gilead Sciences have agreed a ten-year “multi-billion dollar collaboration” to create what they say will be a global R&D leader based in Europe and engaged in...
08.04.2019
- The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious...
11.12.2018
- Gilead Sciences has nabbed Daniel O’Day, head of Roche’s pharma business, as its new chief executive to replace current CEO John Milligan, with effective from March 2019. Both...
31.10.2018
- An antiviral pill taken daily by thousands of HIV-positive men in Australia has led to a “globally unprecedented” reduction in new infections, according to what is being called...
17.04.2018
- For the global specialty chemicals sector, the past two years have been among the most exciting of the young millennium. Many mergers and acquisitions were in the spotlight in 2017...
